vTv Therapeutics Inc.
VTVT
$22.23
-$0.27-1.20%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 24.02% | 7.66% | -6.47% | -39.88% | 47.73% |
| Total Depreciation and Amortization | 0.00% | -4.35% | 4.55% | -4.35% | 4.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 98.91% | 34.99% | 0.00% | 24.43% | -140.36% |
| Change in Net Operating Assets | 6.35% | -27.95% | 47.69% | -250.00% | 2,779.17% |
| Cash from Operations | 24.82% | 4.62% | 8.26% | -151.72% | 39.72% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | 100.00% | 32.27% | -203.23% |
| Issuance of Common Stock | -100.00% | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | -- | -100.00% | 17,881.56% | -159.62% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22.00% | 41.22% | -115.72% | 3,443.79% | 127.70% |